{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T19:00:08Z","timestamp":1782846008219,"version":"3.54.5"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Assess incidence of hepatic encephalopathy (HE) after transjugular intrahepatic portosystemic shunt (TIPS) in patients treated with 8-10\u00a0mm Controlled Expansion diameter VIATORR\u00ae (VCX) versus 10\u00a0mm diameter first-generation VIATORR\u00ae (Legacy) stent-grafts.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods<\/jats:title>\n            <jats:p>Single-centre retrospective study (January 2015 to March 2024), including 132 adult patients with cirrhosis treated with TIPS due to complications of portal hypertension. Outcomes included post-TIPS new onset overt HE, ascites response, re-bleeding, mortality and portal pressure gradient (PPG) before and after TIPS. Comparisons used Chi square and Fisher\u00b4s exact test for categorical variables and Student\u00b4s t test or Mann\u2013Whitney test for quantitative variables.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Indication for TIPS was refractory ascites (<jats:italic>n<\/jats:italic>\u2009=\u200982) and variceal bleeding (<jats:italic>n<\/jats:italic>\u2009=\u200950). The VCX group (<jats:italic>n<\/jats:italic>\u2009=\u200985) and the Legacy group (<jats:italic>n<\/jats:italic>\u2009=\u200947) had similar new onset overt HE: 37% (31\/85) vs 43% (20\/47), respectively (<jats:italic>p<\/jats:italic>\u2009=\u20090.31); mortality rates (34% [29\/85]) vs 39% [18\/47], respectively, <jats:italic>p<\/jats:italic>\u2009=\u20090.57) and re-bleeding (17% [6\/35] vs 20% [3\/15], respectively, <jats:italic>p<\/jats:italic>\u2009=\u20091.00). Median PPG reduction after TIPS was 10\u00a0mmHg (7 \u2013 13) in the VCX group and 12\u00a0mmHg (9 \u2013 15) in the Legacy group (<jats:italic>p<\/jats:italic>\u2009=\u20090.02). Subgroup analysis revealed post TIPS overt HE rate of 38% (19\/50) in the VCX group vs 53% (17\/32) in the Legacy group (<jats:italic>p<\/jats:italic>\u2009=\u20090.13), with refractory ascites as an indication. Shunt dysfunction rate was 7% (6\/85) in the VCX group (stent thrombosis <jats:italic>n<\/jats:italic>\u2009=\u20096, stenosis or malpositioning <jats:italic>n<\/jats:italic>\u2009=\u20090) and 0% (0\/47) in the Legacy group (<jats:italic>p<\/jats:italic>\u2009=\u20090.09).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>VCX stent grafts induce an immediate lower PPG reduction, which might lead to more stent dysfunctions, but also to a reduction in post-TIPS HE.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s42155-025-00557-8","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T04:25:18Z","timestamp":1748060718000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Controlled expansion stent grafts versus legacy stent grafts for transjugular intrahepatic portosystemic shunt: a single-centre retrospective study on the incidence of hepatic encephalopathy"],"prefix":"10.1186","volume":"8","author":[{"given":"Afonso","family":"Fonseca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6511-6181","authenticated-orcid":false,"given":"Rui","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9613-4553","authenticated-orcid":false,"given":"\u00c9lia","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2516-324X","authenticated-orcid":false,"given":"Ant\u00f3nio","family":"Caetano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2225-5613","authenticated-orcid":false,"given":"Teresa","family":"Neves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7418-551X","authenticated-orcid":false,"given":"In\u00eas Conde","family":"Vasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-8550","authenticated-orcid":false,"given":"Marta","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3044-8474","authenticated-orcid":false,"given":"Tiago","family":"Bilhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"557_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/jgh.15194","volume":"36","author":"A Khan","year":"2021","unstructured":"Khan A, Maheshwari S, Gupta K, Naseem K, Chowdry M, Singh S. Rate, reasons, predictors, and burden of readmissions after transjugular intrahepatic portosystemic shunt placement. J Gastroenterol Hepatol. 2021;36:775\u201381.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"557_CR2","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.2214\/ajr.169.6.9393198","volume":"169","author":"DA Zuckerman","year":"1997","unstructured":"Zuckerman DA, Darcy MD, Bocchini TP, Hildebolt CF. Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors. AJR Am J Roentgenol. 1997;169(6):1727\u201331.","journal-title":"AJR Am J Roentgenol"},{"key":"557_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0168-8278(95)80325-4","volume":"23","author":"R Jalan","year":"1995","unstructured":"Jalan R, Elton RA, Redhead DN, et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol. 1995;23:123\u20138.","journal-title":"J Hepatol"},{"key":"557_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/jcm13010014","volume":"13","author":"KH Friis","year":"2024","unstructured":"Friis KH, Thomsen KL, Laleman W, Montagnese S, Vilstrup H, Lauridsen MM. Post-Transjugular Intrahepatic Portosystemic Shunt (TIPS) hepatic encephalopathy\u2014a review of the past decade\u2019s literature focusing on incidence, risk factors, and prophylaxis. J Clin Med. 2024;13:14.","journal-title":"J Clin Med"},{"key":"557_CR5","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1002\/hep.23500","volume":"51","author":"P Jepsen","year":"2010","unstructured":"Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study. Hepatology. 2010;51:1675\u201382.","journal-title":"Hepatology"},{"key":"557_CR6","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.jhep.2020.07.013","volume":"73","author":"CF Rose","year":"2020","unstructured":"Rose CF, Amodio P, Bajaj JS, Dhiman RK, Montagnese S, Taylor-Robinson SD, Vilstrup H, Jalan R. Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy. J Hepatol. 2020;73:1526\u201347.","journal-title":"J Hepatol"},{"key":"557_CR7","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1002\/hep.23367","volume":"51","author":"DL Shawcross","year":"2010","unstructured":"Shawcross DL, Shabbir SS, Taylor NJ, Hughes RD. Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis. Hepatology. 2010;51:1062\u20139.","journal-title":"Hepatology"},{"key":"557_CR8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s11547-017-0770-6","volume":"122","author":"P Fonio","year":"2017","unstructured":"Fonio P, Discalzi A, Calandri M, et al. Incidence of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt (TIPS) according to its severity and temporal grading classification. Radiol med. 2017;122:713\u201321.","journal-title":"Radiol med"},{"key":"557_CR9","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00270-018-1992-2","volume":"41","author":"MW Rowley","year":"2018","unstructured":"Rowley MW, Choi M, Chen S, et al. Refractory Hepatic Encephalopathy After Elective Transjugular Intrahepatic Portosystemic Shunt: Risk Factors and Outcomes with Revision. Cardiovasc Intervent Radiol. 2018;41:1765\u201372.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"557_CR10","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jhep.2017.05.006","volume":"67","author":"Q Wang","year":"2017","unstructured":"Wang Q, Lv Y, Bai M, Wang Z, Liu H, He C, et al. Eight millimetre covered TIPS does not compromise shunt function but reduces hepatic encephalopathy in preventing variceal rebleeding. J Hepatol. 2017;67:508\u201316.","journal-title":"J Hepatol"},{"key":"557_CR11","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","volume":"149","author":"T Sauerbruch","year":"2015","unstructured":"Sauerbruch T, Mengel M, Dollinger M, Zipprich A, Rossle M, Panther E, et al. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents vs hemodynamically controlled medical therapy. Gastroenterology. 2015;149:660\u20138.","journal-title":"Gastroenterology."},{"key":"557_CR12","doi-asserted-by":"publisher","first-page":"9149065","DOI":"10.1155\/2020\/9149065","volume":"2020","author":"J Liu","year":"2020","unstructured":"Liu J, Wehrenberg-Klee EP, Bethea ED, Uppot RN, Yamada K, Ganguli S. Transjugular intrahepatic portosystemic shunt placement for portal hypertension: meta-analysis of safety and efficacy of 8 mm vs. 10 mm stents. Gastroenterol Res Pract. 2020;2020:9149065.","journal-title":"Gastroenterol Res Pract."},{"key":"557_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2010.02.033","volume":"53","author":"O Riggio","year":"2010","unstructured":"Riggio O, Ridola L, Angeloni S, Cerini F, Pasquale C, Attili AF, et al. Clinical efficacy of transjugular intrahepatic portosystemic shunt created with covered stents with different diameters: results of a randomized controlled trial. J Hepatol. 2010;53:267\u201372.","journal-title":"J Hepatol"},{"key":"557_CR14","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1148\/radiol.2017161644","volume":"284","author":"R Miraglia","year":"2017","unstructured":"Miraglia R, Maruzzelli L, Tuzzolino F, Petridis I, D\u2019Amico M, Luca A. Transjugular intrahepatic portosystemic shunts in patients with cirrhosis with refractory ascites: comparison of clinical outcomes by using 8- and 10-mm PTFE-covered stents. Radiology. 2017;284:281\u20138.","journal-title":"Radiology"},{"key":"557_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jvir.2016.06.023","volume":"28","author":"CC Pieper","year":"2016","unstructured":"Pieper CC, Jansen C, Meyer C, Nadal J, Lehmann J, Schild HH, et al. Prospective evaluation of passive expansion of partially dilated transjugular intrahepatic portosystemic shunt stent grafts \u2013 a three-dimensional sonography study. J Vasc Interv Radiol. 2016;28:117\u201325.","journal-title":"J Vasc Interv Radiol"},{"key":"557_CR16","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jvir.2014.08.012","volume":"26","author":"RC Gaba","year":"2015","unstructured":"Gaba RC, Parvinian A, Minocha J, Casadaban LC, Knuttinen MG, Ray CE, et al. Should transjugular intrahepatic portosystemic shunt stent grafts be underdilated? J Vasc Interv Radiol. 2015;26:382\u20137.","journal-title":"J Vasc Interv Radiol"},{"key":"557_CR17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.cgh.2018.01.029","volume":"16","author":"F Schepis","year":"2018","unstructured":"Schepis F, Vizzutti F, Garcia-Tsao G, Marzocchi G, Rega L, De Maria N, et al. Under-dilated TIPS associate with efficacy and reduced encephalopathy in a prospective, non-randomized study of patients with cirrhosis. Clin Gastroenterol Hepatol. 2018;16:1153\u201362.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"557_CR18","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1053\/j.gastro.2017.01.011","volume":"152","author":"G Silva-Junior","year":"2017","unstructured":"Silva-Junior G, Turon F, Baiges A, Cerda E, Garc\u00eda-Criado \u00c1, Blasi A, et al. Timing affects measurement of portal pressure gradient after placement of transjugular intrahepatic portosystemic shunts in patients with portal hypertension. Gastroenterology. 2017;152:1358\u201365.","journal-title":"Gastroenterology"},{"key":"557_CR19","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/S0016-5085(98)70436-6","volume":"114","author":"M Casado","year":"1998","unstructured":"Casado M, Bosch J, Garc\u00eda-Pag\u00e1n JC, Bru C, Ba\u00f1ares R, Bandi JC, et al. Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology. 1998;114:1296\u2013303.","journal-title":"Gastroenterology"},{"key":"557_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s00270-018-2040-y","volume":"42","author":"R Miraglia","year":"2019","unstructured":"Miraglia R, Maruzzelli L, Di Piazza A, Mamone G, Caruso S, Gentile G, et al. Transjugular intrahepatic portosystemic shunt using the new gore VIATORR controlled expansion endoprosthesis: prospective, single-center, preliminary experience. Cardiovasc Intervent Radiol. 2019;42:78\u201386.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"557_CR21","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s00270-017-1807-x","volume":"41","author":"RN Srinivasa","year":"2018","unstructured":"Srinivasa RN, Srinivasa RN, Chick JFB, Hage A, Saad WA. Transjugular intrahepatic portosystemic shunt reduction using the gore VIATORR controlled expansion endoprosthesis: hemodynamics of reducing an established 10-mm TIPS to 8-mm in diameter. Cardiovasc Intervent Radiol. 2018;41:518\u201321.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"3","key":"557_CR22","doi-asserted-by":"publisher","first-page":"100264","DOI":"10.1016\/j.jhepr.2021.100264","volume":"3","author":"M Praktiknjo","year":"2021","unstructured":"Praktiknjo M, et al. Controlled underdilation using novel VIATORR\u00ae controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation. JHEP Rep. 2021;3(3):100264.","journal-title":"JHEP Rep."},{"key":"557_CR23","doi-asserted-by":"publisher","first-page":"4058","DOI":"10.1007\/s10620-020-06716-2","volume":"66","author":"ML Kloster","year":"2021","unstructured":"Kloster ML, Ren A, Shah KY, et al. High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation. Dig Dis Sci. 2021;66:4058\u201362.","journal-title":"Dig Dis Sci"},{"issue":"5","key":"557_CR24","doi-asserted-by":"publisher","first-page":"100319","DOI":"10.1016\/j.jhepr.2021.100319","volume":"3","author":"S Mansour","year":"2021","unstructured":"Mansour S, Lemmers A, Tr\u00e9po E, Moreno C, Deltenre P. The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites. JHEP Rep. 2021;3(5):100319.","journal-title":"JHEP Rep"},{"issue":"1","key":"557_CR25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000507894","volume":"28","author":"S Santos","year":"2020","unstructured":"Santos S, Dantas E, Veloso Gomes F, Luz JH, Vasco Costa N, Bilhim T, Calinas F, Martins A, Coimbra E. Retrospective study of transjugular intrahepatic portosystemic shunt placement for cirrhotic portal hypertension. GE Port J Gastroenterol. 2020;28(1):5\u201312.","journal-title":"GE Port J Gastroenterol."},{"issue":"2","key":"557_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/hep.27210","volume":"60","author":"H Vilstrup","year":"2014","unstructured":"Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, Weissenborn K, Wong P. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715\u201335.","journal-title":"Hepatology"},{"issue":"3","key":"557_CR27","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10620-023-08256-x","volume":"69","author":"A Mukund","year":"2024","unstructured":"Mukund A, Aravind A, Jindal A, Tevethia HV, Patidar Y, Sarin SK. Predictors and Outcomes of Post-transjugular Intrahepatic Portosystemic Shunt Liver Failure in Patients with Cirrhosis. Dig Dis Sci. 2024;69(3):1025\u201334.","journal-title":"Dig Dis Sci"},{"key":"557_CR28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","volume":"40","author":"DK Filippiadis","year":"2017","unstructured":"Filippiadis DK, Binkert C, Pellerin O, et al. Cirse Quality Assurance Document and Standards for Classification of Complications: The Cirse Classification System. Cardiovasc Intervent Radiol. 2017;40:1141\u20136.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"5","key":"557_CR29","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1007\/s00270-023-03383-4","volume":"46","author":"T Dell","year":"2023","unstructured":"Dell T, Menne M, Wagenpfeil J, et al. How Controlled is the Expansion of VIATORR CX? Cardiovasc Intervent Radiol. 2023;46(5):658\u201363. https:\/\/doi.org\/10.1007\/s00270-023-03383-4.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"557_CR30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00270-023-03450-w","volume":"46","author":"O Ahmed","year":"2023","unstructured":"Ahmed O, Yu Q. Transjugular Intrahepatic Portosystemic Shunt Placement: Entering the Era of Controlled Expansion. Cardiovasc Intervent Radiol. 2023;46(6):823\u20134. https:\/\/doi.org\/10.1007\/s00270-023-03450-w.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"557_CR31","doi-asserted-by":"publisher","first-page":"4779","DOI":"10.3748\/wjg.v23.i26.4779","volume":"23","author":"S-H Luo","year":"2017","unstructured":"Luo S-H, Chu J-G, Huang H, Yao K-C. Effect of initial stent position on patency of transjugular intrahepatic portosystemic shunt. World J Gastroenterol. 2017;23:4779\u201387. https:\/\/doi.org\/10.3748\/wjg.v23.i26.4779.","journal-title":"World J Gastroenterol"},{"key":"557_CR32","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1055\/s-0034-1385430","volume":"53","author":"J Klasen-Sansone","year":"2015","unstructured":"Klasen-Sansone J, et al. TIPS geometry influences patency. Z Gastroenterol. 2015;53:28\u201332. https:\/\/doi.org\/10.1055\/s-0034-1385430.","journal-title":"Z Gastroenterol"},{"issue":"1","key":"557_CR33","doi-asserted-by":"publisher","first-page":"3559","DOI":"10.1038\/s41598-022-07595-5","volume":"12","author":"C Meyer","year":"2022","unstructured":"Meyer C, Paar P\u00e9rez AM, Chang J, Sprinkart AM, B\u00f6hling N, Luu AM, K\u00fctting D, Jansen C, Luetkens J, Bischoff LM, Attenberger U, Strassburg CP, Trebicka J, Wolter K, Praktiknjo M. Cranial stent position is independently associated with the development of TIPS dysfunction. Sci Rep. 2022;12(1):3559.","journal-title":"Sci Rep"},{"issue":"5","key":"557_CR34","doi-asserted-by":"publisher","first-page":"3346","DOI":"10.1007\/s00330-021-08437-0","volume":"32","author":"SH Sun","year":"2022","unstructured":"Sun SH, Eche T, Dorczynski C, Otal P, Revel-Mouroz P, Zadro C, Partouche E, Fares N, Maulat C, Bureau C, Schwartz LH, Rousseau H, Dercle L, Mokrane FZ. Predicting death or recurrence of portal hypertension symptoms after TIPS procedures. Eur Radiol. 2022;32(5):3346\u201357.","journal-title":"Eur Radiol"},{"key":"557_CR35","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1007\/s00270-024-03866-y","volume":"47","author":"P Lucatelli","year":"2024","unstructured":"Lucatelli P, Krajina A, Loffroy R, et al. CIRSE Standards of Practice on Transjugular Intrahepatic Portosystemic Shunts. Cardiovasc Intervent Radiol. 2024;47:1710\u201326.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"557_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00270-023-03410-4","volume":"46","author":"A Ushinsky","year":"2023","unstructured":"Ushinsky A, Kim D, Darcy M, et al. Impact of General Anesthesia on the Right Atrial Pressure During Transjugular Intrahepatic Portosystemic Shunt Creation: A Propensity Score Match Analysis. Cardiovasc Intervent Radiol. 2023;46:643\u20138.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"557_CR37","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1053\/j.gastro.2017.01.011","volume":"152","author":"G Silva-Junior","year":"2017","unstructured":"Silva-Junior G, Turon F, Baiges A, et al. Timing affects measurement of portal pressure gradient after placement of transjugular intrahepatic portosystemic shunts in patients with portal hypertension. Gastroenterology. 2017;152:1358\u201365.","journal-title":"Gastroenterology."},{"issue":"2","key":"557_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jhep.2024.08.007","volume":"82","author":"Y Lv","year":"2025","unstructured":"Lv Y, et al. Identifying the optimal measurement timing and hemodynamic targets of portal pressure gradient after TIPS in patients with cirrhosis and variceal bleeding. J Hepatol. 2025;82(2):245\u201357.","journal-title":"J Hepatol."},{"key":"557_CR39","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s42155-024-00489-9","volume":"7","author":"W Li","year":"2024","unstructured":"Li W, Liu M, Guan S, et al. Comparison of outcomes for transjugular intrahepatic portosystemic shunt creation: Viatorr versus Fluency versus a bare stent\/Fluency stent combination. CVIR Endovasc. 2024;7:76.","journal-title":"CVIR Endovasc"},{"issue":"2","key":"557_CR40","first-page":"89","volume":"2","author":"M R\u00f6ssle","year":"2023","unstructured":"R\u00f6ssle M, Bettinger D, Thimme R. Michael Schultheiss. The transjugular intrahepatic portosystemic shunt: Smaller stent diameters are required to optimize pressure response, iLIVER. 2023;2(2):89\u201396.","journal-title":"The transjugular intrahepatic portosystemic shunt: Smaller stent diameters are required to optimize pressure response, iLIVER"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-025-00557-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-025-00557-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-025-00557-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T17:02:59Z","timestamp":1748106179000},"score":1,"resource":{"primary":{"URL":"https:\/\/CVIRendovasc.springeropen.com\/articles\/10.1186\/s42155-025-00557-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["557"],"URL":"https:\/\/doi.org\/10.1186\/s42155-025-00557-8","relation":{},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"8 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board approval for the retrospective analysis was obtained and all patients provided informed consent to perform TIPS.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors and institution consent publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Tiago Bilhim is a paid consultant for Merit Medical and has received speaker fees for Philips Medical, Cook Medical, Terumo and is a stock holder for EmbolX.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}